Schwarz, G.
Kanber, B.
Prados, F.
Browning, S.
Simister, R.
Jäger, R.
Ambler, G.
Wheeler-Kingshott, C. A. M. Gandini
Werring, David J. http://orcid.org/0000-0003-2074-1861
Funding for this research was provided by:
UCLH Biomedical Research Centre
Article History
Received: 12 February 2022
Revised: 19 June 2022
Accepted: 19 June 2022
First Online: 21 July 2022
Declarations
:
: DJW has received honoraria from Bayer, Alnylam and NovoNordisk. RS received funding from UCLH/UCL BRC. The remaining authors declare no financial or other conflicts of interest.
: The SIGNaL registry (which contains routinely collected clinical data) is approved by the University College Hospitals NHS Foundation Trust Governance Review Board as a continuous service evaluation of a comprehensive clinical care program (service evaluation 5–201920-SE); for this reason, informed patient consent was not required.